Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers.
Hyunku ShinByeong Hyeon ChoiOn ShimJihee KimYong ParkSuk Ki ChoHyun Koo KimYeonho ChoiPublished in: Nature communications (2023)
Early cancer detection has significant clinical value, but there remains no single method that can comprehensively identify multiple types of early-stage cancer. Here, we report the diagnostic accuracy of simultaneous detection of 6 types of early-stage cancers (lung, breast, colon, liver, pancreas, and stomach) by analyzing surface-enhanced Raman spectroscopy profiles of exosomes using artificial intelligence in a retrospective study design. It includes classification models that recognize signal patterns of plasma exosomes to identify both their presence and tissues of origin. Using 520 test samples, our system identified cancer presence with an area under the curve value of 0.970. Moreover, the system classified the tumor organ type of 278 early-stage cancer patients with a mean area under the curve of 0.945. The final integrated decision model showed a sensitivity of 90.2% at a specificity of 94.4% while predicting the tumor organ of 72% of positive patients. Since our method utilizes a non-specific analysis of Raman signatures, its diagnostic scope could potentially be expanded to include other diseases.
Keyphrases
- early stage
- papillary thyroid
- artificial intelligence
- squamous cell
- raman spectroscopy
- mesenchymal stem cells
- stem cells
- childhood cancer
- deep learning
- lymph node metastasis
- gene expression
- squamous cell carcinoma
- gold nanoparticles
- radiation therapy
- ejection fraction
- genome wide
- bone marrow
- chronic kidney disease
- sentinel lymph node
- prognostic factors
- young adults
- lymph node
- quantum dots